跳至主要内容
临床试验/NCT04735653
NCT04735653已完成不适用

Support, Educate, Empower: The SEE Personalized Glaucoma Coaching Trial

University of Michigan4 个研究点 分布在 1 个国家目标入组 236 人开始时间: 2021年4月27日最近更新:
适应症
干预措施

试验速览

阶段
不适用
状态
已完成
入组人数
236
试验地点
4
主要终点
Mean Percent Electronically Monitored Medication Adherence Over Six Months

研究概览

简要总结

This study will test whether the Support, Educate, Empower (SEE) personalized Glaucoma Coaching Program improves eye drop medication adherence among glaucoma patients compared to enhanced standard care in a randomized controlled clinical trial. As a secondary outcome, the study will test whether glaucoma related distress decreases among SEE program participants compared to the control group.

The study hypothesis is that glaucoma patients with poor adherence who receive motivational-interviewing based counseling and personalized education from a trained non-physician glaucoma coach through the SEE Program will improve their medication adherence compared to glaucoma patients standard care enhanced by additional educational handouts.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Health Services Research
盲法
Single (Outcomes Assessor)

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Taking greater or equal to 1 ocular hypotensive medication with a diagnosis of any kind of glaucoma, suspected glaucoma or ocular hypertension
  • Did not opt-out from recruitment letter

排除标准

  • Do not speak English
  • Have a diagnosed serious mental illness (for example, Schizophrenia)
  • Diagnosed cognitive impairment
  • Do not instill their own eye drops
  • Had laser or incisional glaucoma surgery within three months of enrollment or scheduled during the six-month study period
  • Unable to attend all study visits
  • Active ocular infection or uveitis

研究组 & 干预措施

Personalized Glaucoma Coaching

Experimental

This is a six-month personalized glaucoma coaching program where a coach trained in motivational interviewing (MI)-based counseling uses a web-based tool that generates tailored education to help glaucoma patients identify their barriers to optimal medication adherence and explore potential solutions during three in-person coaching sessions. The coach provides between-session support through four phone calls, with two phone calls between the first and second sessions and one call after each subsequent session. Participants can elect to receive any of the following types of alarm when a dose of medication is due: visual or audible alert or automated text or phone call reminder. Glaucoma medication adherence will be monitored electronically for all participants between the baseline visit and the exit visit six months later.

干预措施: Personalized Glaucoma Coaching (Behavioral)

Enhanced standard care

Active Comparator

Participants will receive non-tailored educational materials about glaucoma from leading sources by mail every 2 months for a total of 3 mailings during the 6-month study period. Glaucoma medication adherence will be monitored electronically for all participants between the baseline visit and the exit visit six months later.

干预措施: Enhanced Standard care (Behavioral)

结局指标

主要结局

Mean Percent Electronically Monitored Medication Adherence Over Six Months

时间窗: Up to 6 months

Medication adherence will be measured objectively using electronic monitors with a bottle-in-bottle technique where all glaucoma medications are placed inside electronic pill bottles. An adherent event is defined as using an eye drop medication within a specified time window of a dose on the previous day. Adherence will be calculated as the percentage of doses taken on time divided by total doses prescribed over the six-month study period. The calculation censored participants at the time of withdrawal, loss to follow-up, or disengagement (attended the exit visit but may have gone some time before this visit without adherence monitor activity) and their adherence was calculated only during the reduced time on study. Additionally, times noted where monitors malfunctioned or went unused due to vacation or hospitalization were excluded.

Percentage of Participants Who Achieved >= 80% Medication Adherence Over the 6 Month Study Period

时间窗: Up to 6 months

Medication adherence will be measured objectively using electronic monitors with a bottle-in-bottle technique where all glaucoma medications are placed inside electronic pill bottles. An adherent event is defined as using an eye drop medication within a specified time window of a dose on the previous day. Adherence will be calculated as the percentage of doses taken on time divided by total doses prescribed over the six-month study period. The calculation censored participants at the time of withdrawal, loss to follow-up, or disengagement (attended the exit visit but may have gone some time before this visit without adherence monitor activity) and their adherence was calculated only during the reduced time on study. Additionally, times noted where monitors malfunctioned or went unused due to vacation or hospitalization were excluded. Continuous percentage adherence was dichotomized to a binary outcome as \>= 80% vs \< 80% medication adherence.

次要结局

  • Change in Glaucoma-related Distress(6 months)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Paula Anne Newman-Casey

Assistant Professor of Ophthalmology and Visual Sciences

University of Michigan

研究点 (4)

Loading locations...

相似试验